Tag:

meningitis

Latest Headlines

Latest Headlines

England to provide GSK MenW vaccine to 3 million teens

England has decided to offer meningitis W vaccination to three million teens after a steep rise in cases--and local vaccine giant GlaxoSmithKline will be reaping the benefits.

Pfizer, Novartis: CDC's MenB nod is too narrow

Pfizer and Novartis have snagged a nod from the CDC's Advisory Committee on Immunization Practices for their recently approved meningitis B vaccines. There's just one problem: It doesn't cover nearly as large a population as the pharma giants would like.

WHO approves MenAfriVac for routine infant immunization in sub-Saharan Africa

The affordable meningitis A vaccine, MenAfriVac, has been given to millions of people in Africa's so-called "meningitis belt," and is about to be administered to even more. The World Health Organization approved the shot, previously approved for people aged one to 29, for use in the routine immunization of infants less than one year old in sub-Saharan Africa.

FDA approves Sanofi's Menactra as meningococcal booster

The new nod could boost sales of the French drugmaker's vaccine, a lift it could use after Menactra's top-line haul in 2013 sank to €424 million in a 21.5% slide.

Pfizer, Novartis square off for tussle in meningitis vaccine market

Pfizer and Novartis have been racing to get their meningitis B vaccines to market for years. But as of Tuesday, the contest has never been closer, with both companies submitting approval applications to the FDA. Now, it's up to the agency to decide which shot gets the green light first--and first crack at the wide-open patient pool that comes with it.

Pfizer, Novartis race to market with 'breakthrough' meningitis B vaccines

Both Pfizer and Novartis have picked up the FDA's much-coveted breakthrough-therapy designation for their meningitis B vaccines, and now the rivals have chosen the same day to submit their injections for approval, leaving it up to regulators which will hit the market first.

Sanofi looks to make a splash with meningitis booster-shot push

When looking for celebrity spokespeople, pharma companies want someone who can deliver a health message as a peer might. And for Sanofi, which is trying to spread the word about the importance of meningitis booster shots--amid lagging sales of its vaccines for the deadly disease--that person is 12-time Olympic medalist swimmer Dara Torres.

Sanofi hopes to make a splash with new meningitis vax initiative

According to a new survey, more than two in three mothers have little to no knowledge of the CDC's recommendations for preventing meningococcal meningitis. And if you're a meningitis vaccine maker like Sanofi, that's a troubling statistic

Sanofi steps up meningitis marketing amid lagging Menactra sales

Meningitis vaccine maker Sanofi has launched a new initiative that it hopes will increase awareness of the CDC's recommendations for preventing meningococcal meningitis--and give sales a boost in the process.

Novartis' vaccine unit gets a badly needed booster from the U.K.

The U.K.'s Joint Committee on Vaccination and Immunization (JCVI) is revising its stance on Novartis' meningitis B vaccine Bexsero. The jab, originally left off Britain's routine vaccination schedule, has gained the JCVI's nod, supplying a needed boost for the Swiss company's flailing vaccine unit.